# K103750: Nuvasive Traverse Plate System

- Pathway: 510(k) (Special)
- Applicant: Nuvasive, Inc.
- Decided: Mar 3, 2011 after 70 days
- Product code: KWQ (Appliance, Fixation, Spinal Intervertebral Body)
- Device class: 2
- Regulation: 21 CFR 888.3060
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K061778 (2006). 5 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K082070: Nuvasive Lateral Plate System, Nuvasive, Inc. (2008) Summary page 1.
- K070273: Modification to Nuvasive Lateral Plate System, Nuvasive, Inc. (2007) Summary page 1.
- K102514: Nuvasive Spherx II -Mas Deformity Spinal System, Nuvasive, Inc. (2010) Summary page 1.

## Most influential descendants
- K200956: NuVasive Thoracolumbar Plates (2020), 0 descendants of its own

## Indications for use
The NuVasive Traverse Plate System is indicated for use as an adjunct to fusion via a lateral or anterolateral surgical approach above the bifurcation of the great vessels in the treatment of thoracic and thoracolumbar (T1 -L5) spine instability or via the anterior surgical approach, below the bifurcation of the great vessels, in the treatment of lumbar and lumbosacral (Li-Si) spine instability as a result of: 1. Fracture (including dislocation and subluxation) 2. Tumor 3. Degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies) 4. Scoliosis 5. Kyphosis 6. Lordlosis 7. Spinal stenosis 8. Failed previous spine surgery

Source page: https://510kreport.com/device/K103750
Methodology: https://510kreport.com/methodology